Procter & Gamble Health Share Price Today | Stock Price & Procter & Gamble Health Share Screener
As of October 5, 2026, the live Procter & Gamble Health share price (NSE: PGHL) is ₹5,300.00 on NSE and ₹5,301.40 on BSE, down 1.12% from the previous close, with shares trading between ₹5,280.00 and ₹5,403.50 in today's trading session, and a 52-week range of ₹4,778.60–₹6,918.50. Check PGHL 52-week high low for the annual price range and momentum. Use the Procter & Gamble Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Procter & Gamble Health opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹1,482 and net income of ₹357, with EBITDA of ₹515, an operating margin of 33.0% and a profit margin of 24.1%.
Procter & Gamble Health Share Price Chart
Track the current stock price of Procter & Gamble Health with an interactive chart. Analyse PGHL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Procter & Gamble Health stock quote in one place.
The quote of ₹5,300.00 sits between the 52-week low of ₹4,778.60 and the 52-week high of ₹6,918.50, and the latest session moved -1.12% from the previous close.
Procter & Gamble Health Company Profile - Fundamental Screener
Screen Procter & Gamble Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PGHL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE199A01012.
Company Details
Classification
Identifiers and Leadership
Procter & Gamble Health Balance Sheet Screener
Screen PGHL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹841, up from ₹794 in 2025.
Latest statistics put total assets at ₹841 and shareholder funds at ₹525, with a leverage ratio of 0.02.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 841 | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 |
| Current Assets | 556 | 526 | 524 | 796 | 608 | 727 | 954 | 1,534 | 752 | 636 |
| Fixed Assets | 102 | 116 | 129 | 144 | 112 | 104 | 101 | 104 | 115 | 111 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 62 | 42 | 37 | 46 | 40 | 44 | 42 | 27 | 33 | 29 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 525 | 537 | 538 | 751 | 617 | 704 | 906 | 1,540 | 733 | 664 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | 508 | 520 | 522 | 734 | 600 | 687 | 890 | 1,524 | 717 | 647 |
Procter & Gamble Health Income Statement Screener - Profit & Revenue Analysis
Screen Procter & Gamble Health income statement and profit fundamentals. Analyze PGHL quarterly results. Procter & Gamble Health reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹1,482 and net profit was ₹357, equal to earnings per unit of ₹215.00, at an operating margin of 33%.
In that period expenses were ₹967, interest cost ₹1 and tax ₹127. The next period listed, 2026-March, shows revenue of ₹1,425 and net profit of ₹327.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||||||
| Revenue | 1,482 | 1,425 | 945 | 1,167 | 1,248 | 1,128 | 1,027 | 1,425 | 873 | 722 | 1,017 | 963 |
| Expenses | 967 | 951 | 616 | 845 | 905 | 847 | 763 | 1,041 | 701 | 621 | 877 | 856 |
Operating Costs and Margins | ||||||||||||
| EBITDA | 515 | 474 | 329 | 322 | 343 | 281 | 264 | 384 | 173 | 101 | 140 | 107 |
| Operating Profit % | 33.00% | 32.00% | 34.00% | 27.00% | 26.00% | 24.00% | 24.00% | 23.00% | 17.00% | 11.00% | 12.00% | 9.00% |
| Depreciation | 24 | 24 | 17 | 27 | 28 | 27 | 30 | 30 | 21 | 19 | 25 | 23 |
| Interest | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | ||||||||||||
| Profit Before Tax | 490 | 450 | 312 | 273 | 314 | 253 | 233 | 355 | 158 | 99 | 115 | 83 |
| Tax | 127 | 123 | 77 | 72 | 85 | 61 | 57 | 101 | 56 | 38 | 36 | 30 |
| Net Profit | 357 | 327 | 234 | 201 | 230 | 193 | 177 | 254 | 102 | 61 | 79 | 54 |
| EPS | 215.00 | 197.00 | 141.00 | 121.00 | 138.00 | 116.00 | 107.00 | 153.00 | 505.27 | 56.60 | 47.70 | 32.30 |
Procter & Gamble Health Cash Flow Screener - Liquidity Fundamentals
Screen PGHL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹338, and net cash flow was an outflow of ₹5.
Over the same period, investing activities provided ₹1 and financing activities used ₹344.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 338 | 169 | 228 | 236 | 170 | 247 | 235 | -130 | 54 | 107 |
| Investing Activities | 1 | 10 | -7 | -22 | -26 | -32 | 165 | 1,270 | -48 | -75 |
Financing and Net Cash | ||||||||||
| Financing Activities | -344 | -235 | -418 | -99 | -289 | -387 | -883 | -30 | -22 | -15 |
| Net Cash Flow | -5 | -57 | -197 | 116 | -145 | -172 | -483 | 1,109 | -16 | 17 |
Procter & Gamble Health Shareholding Pattern Screener
See Procter & Gamble Health shareholding pattern with promoter, FII, and DII holdings. Check Procter & Gamble Health promoter holding and ownership changes for PGHL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 51.82%, foreign institutions 6.20%, domestic institutions 13.68% and the public 23.17%, spread across 50,883 shareholders.
The shareholder count was 50,883 in 2026-Mar, compared with 49,056 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
Institutional Investors | ||||||||
| FII Holding | 6.20% | 6.33% | 6.87% | 6.99% | 7.24% | 6.97% | 6.24% | 6.40% |
| DII Holding | 13.68% | 12.44% | 14.21% | 14.16% | 13.91% | 13.84% | 13.73% | 14.55% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.17% | 23.56% | 21.90% | 21.89% | 22.15% | 22.43% | 22.61% | 21.82% |
| Other Holding | 5.14% | 5.85% | 5.21% | 5.14% | 4.89% | 4.94% | 5.60% | 5.41% |
| Shareholder Count | 50,883 | 49,056 | 53,993 | 52,478 | 50,006 | 49,302 | 56,778 | 55,923 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Procter & Gamble Health. Procter & Gamble Health dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹205.00 per unit for 2026-March, a yield of 3.82%, compared with ₹125.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹205.00, ₹125.00 and ₹260.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹205.00 | 3.82% |
| 2025-March | ₹125.00 | 2.60% |
| 2024-March | ₹260.00 | 5.05% |
| 2023-March | ₹95.00 | 2.02% |
| 2022-March | ₹52.50 | 1.12% |
| 2021-March | ₹130.00 | 3.25% |
| 2020-March | ₹230.00 | 3.71% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹440.00 | 11.91% |
| 2017-March | ₹15.00 | 1.00% |
Procter & Gamble Health Stock Index Membership - Nifty & Sensex
See which indices include Procter & Gamble Health stock. Check PGHL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 6 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.
Complete Index List
Procter & Gamble Health Market Events Screener - Corporate Actions
Get Procter & Gamble Health corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Procter & Gamble Health stock events that may affect PGHL share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 2, 2026, with a record date of November 2, 2026.
It is followed by Annual General Meeting dated September 3, 2026 and Dividend dated August 27, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-02 | 2026-11-02 | Quarterly Result Announcement | NA | -6.17% |
| 2026-09-03 | 2026-09-03 | Annual General Meeting | NA | -0.74% |
| 2026-08-27 | 2026-08-27 | Dividend | ₹ 45.00 /share | 0.78% |
| 2026-08-06 | 2026-08-06 | Quarterly Result Announcement | NA | 3.50% |
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | 15.83% |
| 2026-02-12 | 2026-02-12 | Dividend | ₹ 50.00 /share | 4.56% |
| 2026-02-12 | 2026-02-12 | Dividend | ₹ 110.00 /share | 4.56% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | -6.98% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -3.34% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | 1.83% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 45.00 /share | 10.63% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 0.33% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 5.91% |
| 2025-02-21 | 2025-02-21 | Dividend | ₹ 80.00 /share | 1.63% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.43% |
Procter & Gamble Health Competitors Screener - Peer Stocks Comparison
Screen PGHL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 432,120 | 36.04 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 245,532 | 84.24 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 181,333 | 84.71 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 114,284 | 25.27 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 108,576 | 32.50 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 107,198 | 98.20 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 104,707 | 50.04 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,679 | 32.41 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,479 | 25.84 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 92,885 | 16.82 | 29,039 | 26.75% | 5,356 | 31.59 |
Procter & Gamble Health Company Announcements - News & Reports Screener
Screen PGHL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 2, 2026.
The next most recent announcements are dated September 27, 2026 and September 18, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-02 | Board Meeting Intimation for Intimation Of Board Meeting | - |
| 2026-09-27 | Closure of Trading Window | - |
| 2026-09-18 | Intimation Regarding Ease Of Doing Investment - Special Window For Transfer And Dematerialization | - |
| 2026-09-04 | Re-Appointment Of Mr. S. Madhavan As Independent Director Of The Company. | - |
| 2026-09-04 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-03 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-12 | 59Th Annual General Meeting Of The Company | - |
| 2026-08-12 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-12 | Reg. 34 (1) Annual Report. | - |
| 2026-08-12 | Notice Calling The 59Th Annual General Meeting Of The Company. | - |
| 2026-08-10 | Record Date For Purpose Of Dividend | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-06 | Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-06 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-07-15 | Update Regarding CompanyS Annual General Meeting For The Financial Year 2025-26 And Record Date | - |
| 2026-07-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited (The Company) | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-26 | Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 6 2026 | - |
| 2026-06-25 | Announcement under Regulation 30 (LODR)-Change in Management | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹5,300.00, within a 52-week range of ₹4,778.60 to ₹6,918.50. The P/E ratio is 25.87 and the P/B ratio is 17.60, with earnings per unit of ₹197.00. Market capitalisation stands at ₹8,897.27 Cr and the dividend yield is 3.69%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.